Dare Bioscience (DARE) Misses Q1 EPS by 20c

Dare Bioscience (NASDAQ: DARE) reported Q1 EPS of ($0.20). Revenue for the quarter came in at $15.45 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Home Depot (HD) PT Raised to $340 at Stifel Amid 'Sea Change in Investor Sentiment'
• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)